Acadia Healthcare director granted new stock awards
WAUD REEVE B reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
WAUD REEVE B reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Reeve B. Waud reported equity compensation in the form of common stock. On May 6, 2026, he received two stock awards of 9,576 shares and 6,331 shares at a price of $0.00 per share, including shares received in lieu of his 2026 annual cash director retainer. The shares will vest over a three-year period in equal yearly installments beginning May 6, 2027. Following these awards, Waud directly holds 75,859 shares. He is also reported as indirectly holding 653,015 shares through various trusts and Waud Capital Partners, L.L.C., while expressly disclaiming beneficial ownership except to the extent of his pecuniary interest.
Insider Trade Summary
Grant/Award: 15,907 shares
Grant/Award
3 txns
Insider
WAUD REEVE B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 6,331 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 9,576 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 75,859 shares (Direct);
Common Stock — 653,015 shares (Indirect, See Footnotes)
Footnotes (5)
- F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
- F2. Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2026 in shares of common stock.
- F3. The shares are owned of record as follows: (i) 225,519 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"), (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the "2002 CBW Family Trust"), and (vi) 34,500 shares by the Corinna Reeve Waud 2002 Trust ("2002 CRW Family Trust").
- F4. Mr. Waud may be deemed to beneficially own the shares of common stock described above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries, and (D) his being appointed, in June 2023, as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud's parents are beneficiaries.
- F5. Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
Key Figures
Director stock grant 1: 9,576 shares at $0.00
Director stock grant 2: 6,331 shares at $0.00
Direct holdings after awards: 66,283 shares
+2 more
5 metrics
Director stock grant 1
9,576 shares at $0.00
Common Stock award on May 6, 2026
Director stock grant 2
6,331 shares at $0.00
Common Stock award on May 6, 2026
Direct holdings after awards
66,283 shares
Common Stock directly owned after May 6, 2026 transactions
Indirect holdings
653,015 shares
Common Stock held via trusts and WCP LLC
Vesting schedule
3 years
Vests in equal yearly installments starting May 6, 2027
Key Terms
annual cash retainer, beneficially own, pecuniary interest, Family Trust, +1 more
5 terms
annual cash retainer financial
"Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2026 in shares of common stock"
beneficially own financial
"Mr. Waud may be deemed to beneficially own the shares of common stock described above"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
pecuniary interest financial
"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein"
Family Trust financial
"2012 RBW Jr Family Trust, 2012 CRMW Family Trust, 2002 CBW Family Trust, 2002 CRW Family Trust"
vesting financial
"Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Reeve B. Waud report in this Form 4 for Acadia Healthcare (ACHC)?
Reeve B. Waud reported receiving equity compensation in Acadia Healthcare common stock. He was granted 9,576 shares and 6,331 shares on May 6, 2026, as director-related awards, with no cash purchase price, and updated his direct and indirect share holdings accordingly.
How do the new Acadia Healthcare (ACHC) stock awards to Reeve B. Waud vest?
The newly reported Acadia Healthcare stock awards to Reeve B. Waud vest over three years. The shares vest in equal yearly installments, beginning on May 6, 2027, creating a multi-year alignment between the director’s compensation and the company’s long-term performance.
What indirect Acadia Healthcare (ACHC) holdings are associated with Reeve B. Waud?
The filing lists 653,015 Acadia Healthcare shares held indirectly through the Halcyon Trust, Waud Capital Partners, L.L.C., and several family trusts. Waud may be deemed to beneficially own these shares but expressly disclaims beneficial ownership except to the extent of his pecuniary interest.
Does this Acadia Healthcare (ACHC) Form 4 show any open-market buys or sells by Reeve B. Waud?
The Form 4 does not show open-market purchases or sales by Reeve B. Waud. It reports stock awards coded as grants at a zero dollar price and updates his direct and indirect holdings, reflecting compensation and ownership structure rather than trading activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates